The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs Ulrich Klotz Leading Article 30 September 2012 Pages: 271 - 279
The Clinical Pharmacokinetics of Escitalopram Niranjan Rao Review Article 30 September 2012 Pages: 281 - 290
Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis Florian M. E. WagenlehnerWolfgang WeidnerKurt G. Naber Review Article 30 September 2012 Pages: 291 - 305
Effect of Time, Injury, Age and Ethanol on Interpatient Variability in Valproic Acid Pharmacokinetics after Traumatic Brain Injury Gail D. AndersonNancy R. TemkinH. Richard Winn Original Research Article 30 September 2012 Pages: 307 - 318
Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin’s Lymphoma and its Effect on Myelotoxicity Stefan WildeAlexander JetterUwe Fuhr Original Research Article 30 September 2012 Pages: 319 - 333
Safety, Pharmacokinetics and Pharmocodynamics of Recombinant Human Porphobilinogen Deaminase in Healthy Subjects and Asymptomatic Carriers of the Acute Intermittent Porphyria Gene Who Have Increased Porphyrin Precursor Excretion Eliane SardhLillan RejkjærPauline Harper Original Research Article 30 September 2012 Pages: 335 - 349
Tolerability, Safety and Pharmacokinetics of the FGLL Peptide, a Novel Mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteers Ravi AnandMichael SeiberlingRolf Pokorny Original Research Article 30 September 2012 Pages: 351 - 358